Drug Prices: So Much For Restraint
Just three years ago, Hillary Rodham Clinton had drugmakers quaking at the threat of price controls. With health-care reform looming, some 18 big companies vowed publicly to rein in increases. Now, the First Lady has retreated from policy issues, health reform is comatose, and drug prices are climbing again--some far faster than inflation. The drug companies, complains Philip A. Brill, a pharmacist in Wynnewood, Pa., "are gouging us."
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.